A new bill in the Michigan legislature would allow law enforcement to determine if drivers are operating a vehicle while impaired through oral fluid screenings.

The DEA National Take Back Day is scheduled 10 a.m.-2 p.m. Saturday, April 26, at the Lake Arthur Police Department. The annual event is held to address the public safety issue of unneeded ...

The Post reached out to Colorado’s six licensed marijuana testing companies and heard back from two — SC Labs ... and marketing materials. So far, 13 California companies have joined ECCO ...

But one thing hasn't changed—mandatory drug testing. Whether it's for pre-employment screening, athletic competitions, court-mandated evaluations, or insurance policies, THC detection is still a ...

Eli Lilly has met its goal of achieving semaglutide-like efficacy with an oral GLP-1 drug. The phase 3 study linked the oral GLP-1 drug orforglipron to similar reductions in blood glucose and body ...

Drug manufacturer Eli Lilly's weight loss pill has completed late-stage trials for people with type 2 diabetes. The pill could offer an alternative to injectables. U.S. Supreme Court ends 2-year ...

California regulators have suspended a prominent testing lab’s license “indefinitely” for alleged infractions that include potency inflation, according to records obtained by MJBizDaily. BelCosta Labs ...

The early detect test statistically combines and quantifies 27 biochemical pathways encompassing seven molecular mechanisms that measure the oral biochemical functions leading to systemic inflammation ...

Traditionally, 25-OH vitamin D levels are measured via lab testing, which has seen a significant increase in demand and associated expenses for government-backed healthcare systems over the past ten ...

Israeli researchers say they have developed a blood test that can accurately tell whether ... is a big step forward in how we understand and detect Parkinson’s,” said lead scientist Prof.

Pfizer said it would end development of its oral GLP-1 receptor agonist danuglipron for weight loss due to a potential case of drug-induced liver injury. After the Trump administration opted not ...

Pfizer bounces back in obesity, moving once-daily oral drug toward pivotal trials after earlier missteps Pfizer scrapped another oral GLP-1 candidate, lotiglipron, in 2023 after seeing elevated ...